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Abstract
Ischemia reperfusion injury (IRI) is a leading cause of acute kidney injury, a common problem worldwide associated with
significant morbidity and mortality. We have recently examined the role of microRNAs (miRs) in renal IRI using expression
profiling. Here we conducted mathematical analyses to determine if differential expression of miRs can be used to define a
biomarker of renal IRI. Principal component analysis (PCA) was combined with spherical geometry to determine whether
samples that underwent renal injury as a result of IRI can be distinguished from controls based on alterations in miR
expression using our data set consisting of time series measuring 571 miRs. Using PCA, we examined whether changes in
miR expression in the kidney following IRI have a distinct direction when compared to controls based on the trajectory of
the first three principal components (PCs) for our time series. We then used Monte Carlo methods and spherical geometry
to assess the statistical significance of these directions. We hypothesized that if IRI and control samples exhibit distinct
directions, then miR expression can be used as a biomarker of injury. Our data reveal that the pattern of miR expression in
the kidney following IRI has a distinct direction based on the trajectory of the first three PCs and can be distinguished from
changes observed in sham controls. Analyses of samples from immunodeficient mice indicated that the changes in miR
expression observed following IRI were lymphocyte independent, and therefore represent a kidney intrinsic response to
injury. Together, these data strongly support the notion that IRI results in distinct changes in miR expression that can be
used as a biomarker of injury.
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Introduction
Ischemia reperfusion injury (IRI) is a leading cause of acute
kidney injury [1,2,3], that results in tubulointerstitial inflamma-
tion, cell death and a poorly understood repair process [4,5,6].
Renal IRI also leads to activation of innate and adaptive immune
responses, resulting in tissue damage [7,8]. The pathophysiology of
injury and subsequent repair resulting from IRI has been
extensively investigated, yet it is unknown how these processes
are regulated and treatment is limited to supportive measures
[2,9].
microRNAs (miRs) are a class of small, noncoding RNAs that
regulate gene expression [10,11,12,13]. Given the emerging role of
miRs in the control of various physiological processes, we
hypothesized that miRs might play a critical role in the regulation
of responses to renal IRI. To test this hypothesis we performed
miR expression profiling on RNA isolated from the kidneys of
mice that underwent unilateral warm ischemia and sham controls
[14]. We determined that IRI leads to lymphocyte independent
alterations in miR expression profiles, leading us to hypothesize
that changes in miR expression could be used as a biomarker of
renal injury resulting from ischemia and subsequent reperfusion.
Here, we performed a detailed mathematical analysis of miR
expression data using principal component analysis (PCA) in order
to test the hypothesis that differential expression of miRs might
serve as a biomarker of injury. We used spherical geometry to
determine whether differences observed in miR expression
between groups are significant.
Results
PCA of miR expression following unilateral warm IRI
To examine the possibility that changes in miR expression could
be used as a biomarker for IRI, we observed changes in miR
expression in C57BL/6 on days 1, 3, 5, 7, 14, 21 and 30 after
warm ischemia (IRI) or sham surgery [14]. miR expression in
naı ¨ve kidneys was used as a day 0 data point. We recorded
expression of 571 miRs in miRBase 10.0. miRs with mean signal
PLoS ONE | www.plosone.org 1 August 2011 | Volume 6 | Issue 8 | e23011intensities under 200 were eliminated, leaving 144 miRs for
analysis. Thus, we had a time series for each mouse group
composed of points with 144 dimensions, i.e., points in R
144.W e
then analyzed these time series using principal component analysis
(PCA).
PCA revealed that greater than 95% of the variance observed
between samples from C57BL/6 mice that underwent IRI and
sham controls could be explained by the first 9 principal
components (PCs), with the first 3 accounting for over 65% of
variance (Fig. 1A). Thus, the majority of the variance observed in
this data set can be captured in three dimensions. We analyzed the
first three PCs in order to determine whether changes in miR
expression following IRI could be distinguished from those
observed in sham controls by generating three-dimensional
variance plots. Three-dimensional variance plots revealed that
relative to naı ¨ve controls, IRI and sham samples showed similar
changes within the first 24 hours resulting in similar linear
trajectories (Fig. 1B–C). After day 1, sham controls exhibited
variance that appeared to fluctuate around the values shown for
day 1. Presumably, this reflects alterations resulting from the
effects of surgery itself. In contrast, the IRI samples exhibited
changes in variance after day 1 that resulted in a visually distinct
trajectory from that of sham controls (Fig. 1B–C), suggesting that
miR expression following IRI is distinct.
Defining the significance of distinct patterns of miR
expression based on PCA
We next sought to assign a P-value to our visual assessment of
the trajectories that our PCA produced in order to determine
statistical significance. Each data point in the above PCA is a
three-dimensional representation of the changes in miR expression
for a given sample at a given time point. In particular, we sought
to determine if there are well-defined sham and IRI directions. In
the case of samples from mice undergoing a sham procedure, we
considered the naı ¨ve control the center of a sphere, and projected
lines from the center of the sphere through each data point (days 1,
3, 5, 7, 14, 21 and 30). We then intersected the lines with the
surface of the sphere to generate a new set of points, and measured
the radius of the smallest circle that contained all of them. (Fig. 2A).
In the case of sham samples, the points generated lie within a circle
of radius 21.7u. To determine whether the circle generated
represents a direction, we took as our null hypothesis that the
trajectory in question is a random walk. Using Monte Carlo
methods we found that 600 in 10,000 random trajectories lie
within a circle of equal or smaller size giving a P-value of 0.06.
Thus, there does not appear to be a sham direction based on
changes in the first three PCs.
For mice undergoing IRI, we considered the day 1 samples the
center of the sphere, and then projected lines from the center of
the sphere through the subsequent data points (days 3, 5, 7, 14, 21
and 30). We then intersected these lines with the surface of the
sphere to generate a new set of points, and measured the radius of
the smallest circle that contained all of them (Fig. 2A). We
projected from day 1 because based on histological data and PCA
it is apparent that both tissue damage and alterations in miR
expression occur after day 1. For IRI samples, the points
generated fall within a circle of radius 14.6u giving a P-value of
0.0069 based on the Monte Carlo methods used above. The
question arises, are these two groups distinct? To test this, we
compared the spread of each group on the sphere (as measured by
their spherical standard deviation) to the angular separation
between the two groups. Dividing the angular separation by the
maximum of the spherical standard deviations gives a discrimina-
tion of 8.06. (For details of this computation see Supplemental
Information.) Assessing this discrimination by Monte Carlo
methods shows that the sham and IRI directions are distinct with
a P-value of 0.005.
To validate this analysis, we performed similar calculations using
all 144 reliably detected miRs rather than restricting our analysis to
the first three PCs. We found that the radius angle of changes in
miR expression in sham controls was 29.4u with a spherical
standard deviation of 25.5u. Using Monte Carlo methods we
obtained a P-value of 0.0001. Thus, analysis of the full 144 member
set indicated that sham treatment results in a trajectory of variation
in miR expression with a well-defined direction. Similarly, the
radius angle of changes in miR expression in IRI samples was 23.8u
with a spherical standard deviation of 22.3u. This resulted in a P-
value of ,0.0001, confirming that changes in miR expression over
time followingIRIrepresenta well-defineddirection.Thesham and
IRI samples are separated by a radius angle of 107.3u, with a
discrimination of 4.2. This corresponds to a P-value of ,0.0001.
Figure 1. Principal component analysis of miR expression following unilateral warm IRI. Panel A, shown are variance plots of the first 9
PCs. The first 9 PCs account for over 90% of variance, while the first 3 PCs account for over 65% of variance. Panel B, three-dimensional plot of the first
three PCs for mice undergoing either a sham procedure (red line), or IRI (blue line). Samples for naı ¨ve C57BL/6 mice are shown as a black dot.
Numbers shown represent the time point analyzed in days. Panel C, shown is the plot from Panel B rotated clockwise in order to highlight differences
observed for PC1 between samples. Because of the obvious constraints in depicting three-dimensional data as a two-dimensional figure we strongly
encourage viewing original plots provided as .avi movies in the Supplemental Materials (Movie S1).
doi:10.1371/journal.pone.0023011.g001
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random event, but rather reflects distinct alterations in miR
expression. The results indicate that the pattern of changes in
miR expression is observed as early as day 3 after injury and is
maintained throughout the course of the experiment. This suggests
that the overall changes in miR expression we observed are due to a
single process of response to injury. We therefore conclude that miR
expression may be useful as a biomarker of IRI.
The injury signature defined by PCA of miR expression
data reflects a lymphocyte independent process
To examine the extent to which lymphocytes may affect miR
expression profiles, we performed sham and IRI surgery on
immunodeficient RAG-1 deficient mice (Rag-1
2/2 mice) and RAG-
2/common c-chain cytokine receptor double knockout mice (Rag-2/
cc
2/2 mice.) We examined miR expression over a 14-day time course
a sd e s c r i b e d[ 1 4 ]a n da sb e f o r e ,u s e dn a ı ¨ve kidneys for each strain for
day zero. We then used PCA on the resulting microarray data. This
revealed that the first 10 PCs accounted for 92% of the variance, while
the first three PCs account for 65% of variance. Thus, the majority of
variance can be analyzed in three dimensions.
Three-dimensional variance plots of the first three PCs
indicated that naive Rag-2/cc
2/2 and Rag-1
2/2 mice exhibit
an initial miR expression pattern that is distinct from wild-type
C57BL/6 mice prior to any treatment (Fig. 3A). These data
suggest that baseline levels of miR expression are different in the
kidneys of immunodeficient and immunocompetent mice. In the
immunodeficient mice, sham injury resulted in a trajectory that,
after day 1, seems to fluctuate around the initial response (Fig. 3A).
With respect to this observation they are similar to the C57BL/6
mice. IRI samples from Rag-2/cc
2/2 and Rag-1
2/2 mice also
exhibited alterations in miR expression that paralleled those
observed for C57BL/6 IRI samples (Fig. 3A). Thus, changes
observed in miR expression following IRI in C57BL/6, Rag-2/
cc
2/2 and Rag-1
2/2 mice are similar, and distinct from the
changes observed in sham controls. These data suggest that the
observed alterations in miR expression occur in a lymphocyte
independent manner, and most likely reflect a kidney intrinsic
signature of renal injury that may be useful as a biomarker.
Defining the significance of a lymphocyte independent
pattern of changes in miR expression
The question arises, are the responses of the immunodeficient
mice to IRI similar to those of the C57BL/6 mice? To study this,
we performed PCA on the combined data for all groups (Fig. 3A).
As before we defined directions for the C57BL/6 IRI mice by
taking the day 1 data point and projecting through the subsequent
data points. For the immunodeficient mice, we used the day zero
as our center of projection. We made this choice because the
immunodeficient mice do not show an initial sham response. We
then graphed these directions on a common sphere, and measured
the angles between them (using spherical standard deviations as we
did above to measure separation between the C57BL/6 sham and
IRI groups). The Rag-1
2/2 and C57BL/6 IRI groups are
separated by 34.5u, while the Rag-2/cc
2/2 and C57BL/6 IRI
groups are separated by 43.1u. Under the null hypothesis that the
immunodeficient response is random, this degree of proximity
would be expected with a P-value of 0.02.
Defining a subset of miRs that can distinguish injured
kidneys that underwent IRI
Our previous work showed that in C57BL/6 mice, expression of
miR-21, miR-20a, miR-146a, miR-199a-3p, miR-214, miR-192,
Figure 2. Determining the significance of distinct patterns of miR expression based on PCA. Panel A, shown are points on the surface of a
sphere generated by, in the case of sham samples, placing the coordinates obtained for PC1-3 from naı ¨ve C57BL/6 kidneys at the center of a sphere
and then projecting individual lines from the center of the sphere through each time point examined (days 1, 3, 5, 7, 14, 21 and 30) to the point
where they crossed the surface of the sphere. The resulting seven points are shown in red for sham samples. The red circle shown is the smallest
circle that contains all seven points, while the black inner circle represents the spherical standard deviation. For IRI samples we placed the coordinates
of PC1-3 obtained for day 1 at the center of the sphere and then projected individual lines from the center of the sphere through each time point
examined (days 3, 5, 7, 14, 21 and 30). The resulting six points are shown in blue. The blue circle shown is the smallest circle that contains all six
points, while the black inner circle represents the spherical standard deviation. Panel B, analysis of the first three PCs of all IRI series as vectors
emanating from the center of a sphere. C57BL/6 samples that underwent IRI are represented in blue. Rag-1
2/2 and Rag-2/cc
2/2 samples that
underwent IRI are shown as grey and black dots respectively. C57BL/6 sham control shown in red. Solid circles represent the smallest possible circle
enclosing each group. Black lines represent standard deviation.
doi:10.1371/journal.pone.0023011.g002
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IRI and sham control groups at all times analyzed [14]. PCA
confirmed that the expression profiles observed for these nine
miRs in IRI and sham samples are distinct (Fig. 3B). Sham
controls exhibit variation that fluctuated around the day 1 values,
reminiscent of what we observed for the entire miR data set
(Fig. 1B–C). And from day 1 onward, IRI samples exhibit
variation that is visually distinct from sham samples. However,
using the first three PCs of variance in these nine miRs, neither the
sham nor IRI directions rose to statistical significance.
We also performed PCA on miR expression data in which these
nine miRs were eliminated from the full data set, a ‘‘digital
knockout’’. This changed the profile of the 3D-plot that was
generated in that the discrimination observed between samples in
each groups was reduced (Fig. 3C). However, the direction of
variance for samples from sham and IRI treated mice remained
significantly different. These data therefore suggest that these nine
differentially regulated miRs are not the only miRs in this set that
could serve as effective biomarkers of renal IRI, although their
expression is different in IRI and sham samples.
Figure 3. Distinct patterns of miR expression based on PCA are lymphocyte independent and can be detected using a limited set of
miRs. Panel A, three-dimensional plot of the first three PCs for C57BL/6 mice undergoing either a sham procedure (red line), or IRI (blue line), Rag-1
2/2
mice undergoing eithera shamprocedure (solidgrey line) orIRI(dotted greyline),or Rag-2/cc
2/2 miceundergoing either asham procedure (solidblack
line)orIRI(dottedblackline).Samplesfornaı ¨veC57BL/6miceareshowasablackdot.Samplesfornaı ¨veRag-1
2/2andorRag-2/cc
2/2 miceareshownas
grey and black stars, respectively. Right panel, shown is the plot to the left rotated clockwise in order to highlight differences in PC1 between samples
(Movie S2). Panel B, PCA of nine differentially expressed miRs. Shown is a three-dimensional plot of the first three PCs obtained by performing PCA on
expression data for miR-21, miR-20a, miR-146a, miR-199a-3p, miR-214, miR-192, miR-187, miR-805 and miR-194 obtained for kidneys from C57BL/6 mice
following IRI (blue line) or sham surgery (red lines) (Movie S3). Panel C, Shown is a three-dimensional plot of the first three PCs obtained by performing
PCA on all expression data obtained for kidneys from C57BL/6 mice following IRI (blue line) or sham surgery (red lines) in which we eliminated miR-21,
miR-20a, miR-146a, miR-199a-3p, miR-214, miR-192, miR-187, miR-805 and miR-194 from the analysis. Samples for naı ¨ve C57BL/6 mice are show as a
black dot with a red center. Numbers shown represent the time point analyzed in days. (Movie S4).
doi:10.1371/journal.pone.0023011.g003
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Using PCA to examine miR expression over a time course we
were able to generate 3 dimensional plots in which it is apparent
that over the course of injury, miR expression changes in a distinct
fashion that can be described based on the trajectory of the lines
obtained by plotting variance for the first 3 PCs. Directions are
naturally represented as points on a sphere. Using this property we
were able to combine Monte Carlo methods and spherical
geometry to assess the statistical significance of these directions.
Using this novel approach we were able to determine that
observed directions are not random events. We suggest that the
apparent directionality of sham and IRI data reflects predictable
alterations in miR expression throughout the course of an injury
response. Importantly, because this approach allows us to analyze
data for individual time points, these results also indicate that the
pattern of changes in miR expression following injury is observed
as early as day 3 and continues throughout the course of the
experiment. This suggests that the overall changes in miR
expression we observed are due to a single process of response
to injury. Thus, these methods allowed us to determine that miR
expression profiling can be used to distinguish between kidneys
that have undergone IRI and sham controls and miR expression
may therefore be useful as a biomarker for IRI.
Based on PCA miR expression profiles in naı ¨ve Rag-2/cc
2/2,
and Rag-1
2/2 kidneys do not appear to be the same as observed
for naı ¨ve C57BL/6 kidneys in that the initial condition described
for naive immunodeficient mice results in a plot is distinct from
that observed for C57BL/6 even though all mice are on the
C57BL/6 background. These data suggest that baseline levels of
miR expression are different in the kidneys of immunodeficient
and immunocompetent mice. We suggest therefore that it is
critical to use caution when comparing the effects of kidney injury
in immunodeficient and immunocompetent mice in terms of
concluding that differences in results obtained are attributable to
immunodeficiency alone since the baseline state of the kidneys
from these animals varies dramatically. Nevertheless, our data
suggest that the trajectories of miR expression changes following
IRI are similar in C57BL/6 and immunodeficient and therefore
lymphocyte independent.
We previously suggested that of the miRs analyzed, nine (miR-
21, miR-20a, miR-146a, miR-199a-3p, miR-214, miR-192, miR-
187, miR-805 and miR-194) stand out as being differentially
expressed in C57BL/6 mice undergoing IRI compared to the
expression observed in mice undergoing a sham procedure [14].
Expression of these miRs in kidneys from mice that underwent IRI
was statistically different from sham kidneys at every time point
analyzed. PCA of these nine miR revealed that the expression
profiles observed in samples from C57BL/6 mice undergoing IRI
and sham controls are distinct. While these nine miRs do not
describe a direction for sham samples, it is apparent that these miRs
describe changes in IRI samples that are visually similar to those
observed when all the miRs are analyzed. Interestingly, these nine
miR do not describe a single direction as observed in the complete
data set, but appear to vary in a single direction from day 1 through
day 14, and then in a similar but separate direction thereafter. We
suggest that this may reflect an initial response to injury that is then
not maintained long-term. This is suggestive of a model in which a
few biologically important miR may be responding in a protective
fashion that is independent of the overall changes in miR expression
which may have a single direction related to injury and death of the
kidney. This also demonstrates that PCA in conjunction with
statistical analysis of the direction of variance is a powerful tool to
discern patterns of responses following injury.
Digital knockout provided a method to assess the contribution
of any given set of miRs to the overall patterns that we have
observed. In our digital knockout experiments the differences
between the direction of miR expression changes in IRI and sham
control groups remained significant. We point out that even
though variance was clearly reduced, the differences between the
direction of miR expression changes in IRI and sham control
groups remained significant. This suggests that the distinction
between sham and IRI groups can be detected by assessing
expression of many different miRs underscoring the validity of
using miR expression as a biomarker of IRI. While we have not
yet determined which subset of miRs distinguish IRI and sham
samples best, we suggest that this approach can be used to define
such a data set, develop novel diagnostic tools and determine
which miRs regulate biological processes related to IRI.
The analysis conducted here leads us to conclude that
differential expression of miRs might serve as a biomarker of
renal injury. However, in order for miR expression to serve as a
biomarker it will be important to determine whether miR
expression has prognostic value and whether miR expression
returns to baseline following a healing response. In terms of
translation into a clinical tool, it will be critical to examine whether
differential expression of miRs can be observed in the blood or
perhaps urine of subjects undergoing IRI. We believe that the data
presented here support that notion that such endeavors are
worthwhile. We also wish to point out that differential expression
of miRs in the context of renal injury also has to potential to reveal
the existence of molecular pathways that may be involved in the
injury or repair response that can be manipulated to prevent
damage or promote healing. Indeed, this type of analysis may
reveal novel druggable targets.
Methods
Animals
10–12 week old male C57BL/6J, B6.129S7-Rag1
tm1Mom/J
(Jackson) and (C57BL/6J6C57BL/10SgSnAi)-[KO]cc-[KO]Rag2
(Taconic) mice were housed and handled in accordance with
institutional policies and procedures. All animal experiments were
approved by the Harvard Standing Committee on Animal Use,
Protocol #04077.
IRI and miR Microarray Analysis
Unilateral warm IRI was induced and miR expression analyzed
by microarray as in [14]. All data is MIAME compliant and has
been deposited in the Geo database. Accession numbers
GSE29495.
Mathematical analysis
Normalization. Our data consist of 29 time points organized
into 6 time series. Each of these data point consists of expression
levels for the 571 miRs of mmu-miRBase 10.0. We thus have
x !
1~ x11 ,',x1 571 ðÞ
. .
.
x !
29~ x29 1,',x29 571 ðÞ
Expression levels below 200 were deemed to be below reliable
detection. We thus took y !
i~ yi 1,',yi 571 ðÞ , where
yij~max 200,xij
  
. We then normalized expression of each miR
to its expression in naı ¨ve C57BL/6 mice. Taking y !
1 to be
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i~ zi1,',zi 571 ðÞ where
zij~
yij
y1j
. Finally, we took the natural log of normalized expression
giving w !
i~ wi1,',wi 571 ðÞ , where wij~ln wij
  
. Notice that if a
miR never reaches the cutoff level of 200, it appears with the value
0 in each w !
i.
Digital Knock-out. Digital knock-out of a set S of miRs
was performed by setting w !0
i~ w0
i1,',w0
i 571
  
where w0
ij~
0 if j[S
wij otherwise
 
prior to performing PCA.
Computations on the sphere. Given two points A and B,
the displacement from A to B is their difference B-A. The direction
from A to B is
B{A
B{A kk
, where the vertical bars denote the
Euclidean norm. When the points in question are in 3-dimensional
space, R
3, this direction is a point on the unit 2-sphere, S
2. Given
two points x ! and y ! on the 2-sphere, their distance on the sphere
is the angle between them, that is, dS2 x !, y !   
~arccos x !: y !   
.
We report these angles in degrees. Given a point x ! on the sphere,
the disk of radius r around that point on the sphere consists of all
points of the sphere within (spherical) distance r of x !.
We have considered time-series, e.g., days 1, 3, 5, 7, 14, 21, 30
of the warm ischemia treated C57 BL/6 mice or days 0, 1, 3, 5, 7,
14, 21, 30 of the sham treated C57BL/6 mice. Let p !
1,', p !
n be
the projection of such a series onto the first three PCs. This gives n-
1 directions
s !
1~
~ p p2{~ p p1
~ p p2{~ p p1 kk
s !
2~
~ p p3{~ p p1
~ p p3{~ p p1 kk
. .
.
s !
n{1~
~ p pn{~ p p1
~ p pn{~ p p1 kk
We take C ~ s s1,',~ s sn{1 ðÞ and r ~ s s1,',~ s sn{1 ðÞ to be the center and the
radius of the smallest circle on the unit sphere which contains
~ s s1,',~ s sn{1. C ~ s s1,',~ s sn{1 ðÞ is not necessarily well defined. For
example it can be taken to be either the north pole or the south
pole if ~ s s1,',~ s sn{1 all lie on the equator. However, this happens
with probability 0. This computation is closely related to finding
the spherical standard deviation of a set of points on the sphere.
(See below.)
We used r ~ s s1,',~ s sn{1 ðÞ to assess the hypothesis that p !
1,', p !
n
define a specific direction. We take as our null hypothesis, the
assumption that this path is a random walk with the displacements
~ p p2{~ p p1,~ p p3{~ p p2,',~ p pn{~ p pn{1 drawn from the uniform distribution
on the 2-sphere. We take as the P-value for the directionality of
p !
1,', p !
n, the probability that a random walk of this form
produces directions enclosed by a circle whose radius is no greater
than r ~ s s1,',~ s sn{1 ðÞ .
We used Monte Carlo methods to assess this probability. We
generate 10,000 such random walks. This required us to generate
points on the 2-sphere randomly chosen from the uniform
distribution. This can be done by choosing x, y and z according
to the normal distribution with 0 mean and standard deviation 1
and dividing (x,y,z) by its norm.
Having generated a random walk p !
1,', p !
n, we needed to find
the center and radius of the smallest circle containing the
directions ~ s s1,',~ s sn{1. To do this, we performed constrained
minimization using Matlab’s fmincon function, that is, we
minimized maximum distance to p !
1,', p !
n given that the center
is constrained to lie on the 2-sphere. Functions such as fmincon are
only guaranteed to find local minima. The local minimum found
may depend on the initial value chosen as a candidate center and
need not be the global minimum. Accordingly, for each set of
directions,~ s s1,',~ s sn{1, we performed this minimization starting at
each of the 8 points
+1,+1,+1 ðÞ
ﬃﬃﬃ
3
p , thus giving an initial point in
each octant. To test the reliability of this choice, we generated
1000 sets of points on the sphere and probed the efficacy of using
these 8 points by generating 20 random starting points for each
set. In each case, the 8-point method provided the minimum value
to within the tolerance of fmincon. Perhaps surprisingly, starting at
the (normalized) mean of ~ s s1,',~ s sn{1, did not always converge to
the minimum radius. We generated 10000 random walks and
computed the minimum radius circle for each of these. We used
the resulting distribution of radii to compute P-values.
Given a set of points~ s s1,',~ s sn{1, there is a closely related way
for finding a center Cs ~ s s1,',~ s sn{1 ðÞ and radius rs ~ s s1,',~ s sn{1 ðÞ .
Rather than finding the center which minimizes the angular
radius of the smallest enclosing circle, we find the center which
minimizes the root mean square of the angular distances to the
points ~ s s1,',~ s sn{1. The resulting radius is the spherical standard
deviation of these points. The enclosing circle has the advantage
of being visually clear. Spherical standard deviation has the
advantage of being more robust with respect to outliers. We have
used both here. (For further discussion of spherical standard
deviation, see [15].)
Finally we note that we have described these computations in
the context of 3-dimensional data resulting from the first 3 PCs of
our time series, in which case the computations are carried out on
the 2-sphere, S
2. The same sorts of computations can be
performed directly on our 144 dimensional data set in which case
they are carried out on the 143-sphere, S
143.
Supporting Information
Movie S1 Principal component analysis of miR expres-
sion following unilateral warm IRI. Movie showing rotation
of three-dimensional plot of the first three PCs for mice
undergoing either a sham procedure (red line), or IRI (blue line).
Samples for naı ¨ve C57BL/6 mice are shown as a black dot.
Numbers shown represent the time point analyzed in days.
(MOV)
Movie S2 Distinct patterns of miR expression based on
PCA are lymphocyte independent. Movie showing rotation
of three-dimensional plot of the first three PCs for C57BL/6 mice
undergoing either a sham procedure (red line), or IRI (blue line),
Rag-1
2/2 mice undergoing either a sham procedure (solid grey
line) or IRI (dotted grey line), or Rag-2/cc
2/2 mice undergoing
either a sham procedure (solid black line) or IRI (dotted black line).
Samples for naı ¨ve C57BL/6 mice are show as a black dot. Samples
for naı ¨ve Rag-1
2/2 and or Rag-2/cc
2/2 mice are shown as grey
and black stars, respectively.
(MOV)
Movie S3 PCA of nine differentially expressed miRs.
Shown is a three-dimensional plot of the first three PCs obtained
by performing PCA on expression data for miR-21, miR-20a,
miR-146a, miR-199a-3p, miR-214, miR-192, miR-187, miR-805
and miR-194 obtained for kidneys from C57BL/6 mice following
IRI (blue line) or sham surgery (red lines).
(MOV)
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differentially expressed miRs.Movie showing the rotation of
a three-dimensional plot of the first three PCs obtained by
performing PCA on all expression data obtained for kidneys from
C57BL/6 mice following IRI (blue line) or sham surgery (red lines)
in which we eliminated miR-21, miR-20a, miR-146a, miR-199a-
3p, miR-214, miR-192, miR-187, miR-805 and miR-194 from the
analysis. Samples for naı ¨ve C57BL/6 mice are show as a black dot
with a red center. Numbers shown represent the time point
analyzed in days.
(MOV)
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